Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
TNF Pharmaceuticals, Inc. (TNFA) had Earnings per Share (EPS) (Basic) of $-0.36 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-1.94M |
|
-- |
|
-- |
|
$2.47M |
|
$-2.47M |
|
$1.35M |
|
$-1.12M |
|
$-1.13M |
|
$-1.12M |
|
$-1.12M |
|
$-1.12M |
|
$-1.13M |
|
$-2.47M |
|
$-2.47M |
|
5.35M |
|
5.35M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.36 |
$-0.36 |
|
| Balance Sheet Financials | |
$6.78M |
|
-- |
|
$12.00M |
|
$18.78M |
|
$4.94M |
|
-- |
|
$5.15M |
|
$10.09M |
|
$8.55M |
|
$-1.81M |
|
$8.69M |
|
7.39M |
|
| Cash Flow Statement Financials | |
$-2.64M |
|
$2.54M |
|
-- |
|
$0.17M |
|
$0.07M |
|
$-0.10M |
|
$0.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.16% |
|
62.22% |
|
-5.99% |
|
-12.94% |
|
$1.18 |
|
$-0.49 |
|
$-0.49 |
|